CORIE GRABOWSKI: Open Payments
NPI 1023527264 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 47 payments from 20 companies in 2025. Trend: 2023 $39 · 2024 $3,129 · 2025 $1,179
Food & beverage: $1,179
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $208 |
| Sumitomo Pharma America, Inc. | 7 | $159 |
| TOLMAR, INC. | 5 | $129 |
| Endo USA, Inc. | 4 | $102 |
| Astellas Pharma US Inc | 3 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Tempus AI, Inc | 2 | $57 |
| Dendreon Pharmaceuticals LLC | 2 | $56 |
| Medtronic, Inc. | 1 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
Products named: ORGOVYX, AMS 700, Xtandi, AVEED, Nubeqa, General - Erectile Dysfunction, RUBRACA, XT CDX.
Industry payments across GA — which companies pay providers there.
